Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Biard

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Circulation|July 14, 2017
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCloé Comarmond, Lucie Biard, Marc Lambert, et al.
Journal of Hepatology|July 8, 2019
TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responsesCloé Comarmond, Valérie Lorin, Cindy Marques, et al.
The British Journal of Ophthalmology|July 16, 2024
Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitisMathilde Leclercq, Pascal Sève, Lucie Biard, et al.
Journal of Autoimmunity|August 21, 2018
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patientsAdrien Mirouse, Lucie Biard, Cloé Comarmond, et al.
Cytotherapy|May 14, 2026
Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trialInés Colmegna, Marie Hudson, Lucie Biard, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
EMBO Molecular Medicine|March 28, 2025
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanomaIkuan Sam, Nadine Benhamouda, Lucie Biard, et al.
Journal of Visualized Experiments : Jove|March 20, 2018
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T CellsClémence Granier, Emeline Vinatier, Elia Colin, et al.
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Stroke|March 31, 2022
Cerebrovascular Ischemic Events in Patients With Takayasu ArteritisAdrien Mirouse, Sandrine Deltour, Delphine Leclercq, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Circulation|July 14, 2017
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCloé Comarmond, Lucie Biard, Marc Lambert, et al.
Journal of Hepatology|July 8, 2019
TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responsesCloé Comarmond, Valérie Lorin, Cindy Marques, et al.
The British Journal of Ophthalmology|July 16, 2024
Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitisMathilde Leclercq, Pascal Sève, Lucie Biard, et al.
Journal of Autoimmunity|August 21, 2018
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patientsAdrien Mirouse, Lucie Biard, Cloé Comarmond, et al.
Cytotherapy|May 14, 2026
Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trialInés Colmegna, Marie Hudson, Lucie Biard, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
EMBO Molecular Medicine|March 28, 2025
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanomaIkuan Sam, Nadine Benhamouda, Lucie Biard, et al.
Journal of Visualized Experiments : Jove|March 20, 2018
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T CellsClémence Granier, Emeline Vinatier, Elia Colin, et al.
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Stroke|March 31, 2022
Cerebrovascular Ischemic Events in Patients With Takayasu ArteritisAdrien Mirouse, Sandrine Deltour, Delphine Leclercq, et al.
Pageof 9